A single center analysis of first-line treatment in advanced KRAS mutant non-small cell lung cancer: real-world practice

Abstract Purpose For the first-line treatment of KRAS mutant non-small cell lung cancer (NSCLC) patients, immunotherapy or platinum-based chemotherapy are the main treatment method. Here, we investigated the clinical efficacy and prognosis those two regimens as first-line treatment in real-world pra...

Полное описание

Библиографические подробности

Главные авторы:	Yanxia Liu, Yuan Gao, Ying Wang, Cong Zhao, Zhiyun Zhang, Baolan Li, Tongmei Zhang
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2022-11-01
Серии:	BMC Cancer
Предметы:	KRAS mutation NSCLC First-line treatment Immunotherapy Antiangiogenic therapy
Online-ссылка:	https://doi.org/10.1186/s12885-022-10236-9
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!